Keyphrases
Healthcare Professionals
98%
Protein Drug
92%
User Centricity
81%
Diluted Solutions
81%
Stability Effect
81%
Drug Supply Chain
81%
Antibody Stability
81%
Swedish Universities
81%
Pharmaceutical Products
81%
Mitigation Measures
81%
University Hospital
81%
Commercial Formulations
81%
Risk Measures
81%
Protein-based
81%
Manufacturing Process
81%
Biological Drugs
81%
Product Users
81%
Product Quality
81%
Ipilimumab
81%
Product Handling
40%
Product Manufacturing
40%
Solution Quality
40%
Gap Current
40%
Drug Quality
40%
Professional User
40%
Regulatory Guidance
40%
Health Consumer
40%
Product Experience
40%
Regulatory Agencies
40%
Professional Patients
40%
Caregivers
40%
Educational Materials
40%
Quality Safety
40%
Drug Manufacturing
40%
Drug Efficacy
40%
Drug Safety
40%
Gemba Walk
32%
Cleanroom
32%
Light Exposure
26%
Monoclonal Antibody
26%
Light Dose
20%
Immune System Diseases
16%
Supply Processes
16%
Temperature Shock
16%
Cancer Systems
16%
Relevant Protein
16%
Stress Factors
16%
Structural Complexity
16%
Pharmacist
16%
Pharmacy
16%
Lack of Access
16%
Safety Concerns
16%
Quality Loss
16%
Vibration Exposure
16%
Major Risk
16%
Double Diamond
16%
Patient Safety
16%
Failure Mode Effect Analysis
16%
Loss of Effectiveness
16%
Lack of Awareness
16%
Distributor
16%
Access to Information
16%
Mitigation Strategies
16%
Risk Factors
16%
Physicochemical Behavior
10%
Soluble Aggregates
10%
Biological Toxicity
10%
Primary Packaging
10%
Combined Stressors
10%
Amino Acid Oxidation
10%
Light Dilution
10%
Physicochemical Stability
10%
Sheet Structure
10%
Acid Deamidation
10%
Deamidation
10%
Secondary Packaging
10%
Yervoy
10%
Saline Solution
10%
Tertiary Structure
10%
Light-induced
10%
Stability Condition
10%
In Cancer
10%
Photodegradation
10%
Artificial Sunlight
10%
Cancer Therapy
10%
Biological Behavior
10%
Glucose Solution
10%
Human Cell Lines
10%
Low Potential
10%
Assure
10%
Active Ingredients
10%
Irradiation
10%
Physicochemical Properties
10%
Cancer Types
10%
Detrimental Effects
10%
Light Effect
10%
Minimum Effective Dose
10%
Chemical Modification
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Monoclonal Antibody
90%
Drug Quality
81%
Ipilimumab
81%
Pharmaceutical Manufacturing
81%
Biological Product
81%
Disease
81%
Excipient
18%
Amino Acid
9%
Glucose
9%